课题基金 / 基金详情

IGF::OT::IGF NEXT-LDHA, MCI-1 & P97 TO 2 - FUNDING BASE AWARD LDHA RAT & MICE MUTIPLE DOSE ADMIN STUDIES 8/15/16-7/30/18 PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER PATIENTS & OTHER DISEASES HHSN2612016

IGF::OT::IGF NEXT-LDHA, MCI-1 & P97 TO 2 - FUNDING BASE AWARD LDHA RAT & MICE MUTIPLE DOSE ADMIN STUDIES 8/15/16-7/30/18 PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER PATIENTS & OTHER DISEASES HHSN2612016
IGF::OT::IGF NEXT-LDHA、MCI-1
批准号：
9363856
负责人：
JULIA KAUFMAN
金额：
$4.46万
依托单位：
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-09-01 至 2018-08-31
来源：
https://reporter.nih.gov/project-details/9363856
关键词：
AwardCancer PatientContractsDevelopmentDiseaseDoseFundingInvestigationMalignant NeoplasmsMusOrganPharmaceutical PreparationsProcessRattusTestingToxic effectanti-cancer therapeuticanticancer activitybaseresearch clinical testing

项目摘要

项目成果

JULIA KAUFMAN的其他基金

相似基金

相关文献

中文摘要
翻译
这种试剂剂正在考虑作为一种抗癌疗法开发。 这项任务的目的是表征一种可能进入抗癌活性临床测试的调查剂的靶器官毒性。 从这项调查中获得的信息被用来确定具有治疗癌症潜力的药物。
英文摘要
The test agent is being considered for development as an anticancer therapeutic. The objective of this task was to characterize the target organ toxicities of an investigative agent that might move forward to clinical testing for anticancer activity. The information obtained from this investigation was used to identify drugs with the potential to treat cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NON-GLP, ORAL TOXICITY AND TOXICOKINETIC STUDIES OF DRUG MOLECULES IN RODENTS AND NON-RODENTS
PERFORMANCE AREA 1 - MANAGEMENT AND OPERATIONS SUPPORT
海外基金